# OnCo record fluciclovine-f18 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fluciclovine-f18/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fluciclovine-f18" ;
  schema:name "Fluciclovine F-18"@en ;
  schema:description "Fluciclovine F-18 was the first PET tracer approved for finding recurrent prostate cancer after treatment (2016), and has been largely superseded since 2020 by PSMA PET."@en ;
  schema:url <https://onco.cc/drugs/fluciclovine-f18/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fluciclovine_(18F)> ;
  owl:sameAs <http://www.wikidata.org/entity/Q25313613> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Axumin> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "diagnostic" ;
  onco:modality "PET radiotracer (synthetic amino acid)" ;
  schema:alternateName "Axumin" ;
  onco:approval "US 2016: PET imaging in men with suspected prostate cancer recurrence based on elevated PSA", "EU 2017: Same" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:companies <https://onco.cc/companies/blue-earth-diagnostics/> ;
  onco:terms <https://onco.cc/terms/biochemical-recurrence/> ;
  onco:trials <https://onco.cc/trials/nct04423211/>, <https://onco.cc/trials/nct04410133/>, <https://onco.cc/trials/nct05479136/> .